VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Patients aged of 18 and over                      │ Patients aged of 18 and over                      │     100 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Satisfying the 1987 American College of           │ Satisfying the 1987 American College of           │     100 │
│ Rheumatology (ACR) criteria for RA                │ Rheumatology (ACR) criteria for RA                │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Receiving a prescription of Adalimumab 40 mg      │ Receiving a prescription of Adalimumab 40 mg      │     100 │
│ subcutaneous every two weeks                      │ subcutaneous every two weeks                      │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients not capable or willing to provide        │ Patients not capable or willing to provide        │     100 │
│ informed consent                                  │ informed consent                                  │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Patients starting Adalimumab less than five half- │ Patients starting Adalimumab less than five half- │     100 │
│ lives after the interruption of a previous anti-  │ lives after the interruption of a previous anti-  │         │
│ TNF therapy                                       │ TNF therapy                                       │         │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤══════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                │   Score │
╞═══════════════════════════════════╪══════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ Patients aged of 18 and over │      52 │
╘═══════════════════════════════════╧══════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 95
Average Levenshtein Ratio of individual lines: 92.0
OverAll Ratio: 93.5
